BridgeMD
New treatment option for Malocclusion, Angle Class II
Official title Treatment of Skeletal Class II Malocclusion With Modified Twin-Block Appliance With Clear Plates
ClinicalTrials.gov ID: NCT05950581
What this study is testing
- What it's testing
- Patients with skeletal class II malocclusion who have a retracted lower jaw will be treated in this study. The efficacy of clear Plates in the treatment of Skeletal Class II Malocclusion will be assessed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 13
You may be able to join if
- \- Patients with mixed dentition at age 10.5-13 years.
- The patient has Skeletal class II malocclusion caused by mandibular retraction ANB \> 5, 8 mm \>O.J\> 5 mm, SNB\<78, angle (NSAr) ≥ ° 125 and normal...
- The patient is willing to accept treatment with a removable device.
- No previous orthodontic treatment
- the growth model is within the normal or horizontal maxillary opening angle of 30 \>MM or angle of 400 \> Björk
You likely can't join if
- -Patients with periodontal disease.
- patients with a neuromuscular disorder.
- patients of class I or III of malocclusion.
- Patients with temporomandibular joint disorder.
- Patients with Skeletal open bite.
- Patients with poor oral and gingival health
See the full eligibility criteria
- \- Patients with mixed dentition at age 10.5-13 years.
- The patient has Skeletal class II malocclusion caused by mandibular retraction ANB \> 5, 8 mm \>O.J\> 5 mm, SNB\<78, angle (NSAr) ≥ ° 125 and normal placement of the upper jaw.
- The patient is willing to accept treatment with a removable device.
- No previous orthodontic treatment
- the growth model is within the normal or horizontal maxillary opening angle of 30 \>MM or angle of 400 \> Björk
- patients do not have an upper alveolar dental protrusion.
- -Patients with periodontal disease.
- patients with a neuromuscular disorder.
- patients of class I or III of malocclusion.
- Patients with temporomandibular joint disorder.
- Patients with Skeletal open bite.
- Patients with poor oral and gingival health
- the presence of a unilateral or bilateral posterior crossbite.
- patients who have upper jaw stenosis and need to be prepared by expansion before functional treatment.
- any patient who does not meet one or more of the Inclusion criteria will be removed from the study.
The study team makes the final eligibility decision.
Where it's taking place
- Hama, Syria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 13 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hama, Syria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.